SCHEMBL8977929

SCHEMBL8977929

Cc1noc(NS(=O)(=O)c2ccccc2N)c1Br

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 18/20 0.76
EDNRB P24530 17/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7224337 0.86 EDNRA (1.00) EDNRAEDNRB
SCHEMBL9063568 0.86 EDNRA (1.00) EDNRAEDNRB
SCHEMBL7222851 0.86 EDNRA (1.00) EDNRAEDNRB
SCHEMBL6767337 0.86 EDNRA (0.76) EDNRAEDNRB
SCHEMBL7850031 0.84 EDNRA (1.00) EDNRAEDNRB
SCHEMBL7222551 0.84 EDNRA (1.00) EDNRAEDNRB
SCHEMBL7715919 0.82 EDNRB (1.00) EDNRAEDNRB
SCHEMBL8673049 0.82 EDNRA (0.72) EDNRAEDNRB
SCHEMBL6152569 0.82 EDNRB (1.00) EDNRAEDNRB
SCHEMBL9063621 0.81 EDNRA (0.70) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5514691-A N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin IMMUNOPHARMACEUTICS, INC. (US) 1996-05-07 US disclosed